NICE has today (Wednesday 9 January), published new medical technology guidance supporting the use of a device to heal fractured bones. TheNICE guidance advises that the EXOGEN ultrasound bone healing ...

The new version of EXOGEN introduces new treatment compliance capabilities – such as a treatment tracking calendar and patient treatment history – to help physicians ensure that patients are ...

DURHAM, N.C.--(BUSINESS WIRE)--Bioventus, a global leader in orthobiologic solutions, is recognizing 25 years of proven bone healing with its EXOGEN Ultrasound Bone Healing System. EXOGEN uses ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

August 4, 2006 — The US Food and Drug Administration (FDA) has approved a bone healing system that accelerates the time to healing in fresh, closed, posteriorly displaced distal radius fractures and ...

The UK cost containment agency, the National Institute of Health and Clinical Excellence (NICE), has issued final guidance recommending the use of Bioventus' innovative new bone healing device EXOGEN ...

SAN FRANCISCO (MarketWatch) -- Smith & Nephew's Plc's orthopaedic trauma & clinical therapies division said Tuesday the Food and Drug Administration has approved its Exogen 4000+ bone healing system.

Last year the National Institute for Health and Care Excellence (NICE) approved a low-intensity ultrasound system, known as Exogen, for use in the NHS on bone fractures that fail to heal after nine ...

Please provide your email address to receive an email when new articles are posted on . Proponents of bone growth stimulators cite accelerated fracture healing as a key benefit. But some surgeons ...

The sponsor identified 3 economic studies, all in UK settings. Taylor et al. (2009) carried out a cost-effectiveness analysis on non-union tibial fractures treated by EXOGEN or by surgery ...